Service de Gastroenterologie, CHU de Nancy, Vandoeuvre Lès Nancy, France.
Service de Gastroenterologie, Hôpital NORD, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Int J Colorectal Dis. 2019 Jun;34(6):1131-1140. doi: 10.1007/s00384-019-03297-z. Epub 2019 May 1.
Biofeedback therapy (BT) is a simple and effective technique for managing outlet constipation and fecal incontinence. Several clinical factors are known to predict BT response, but a 50% failure rate persists. Better selection of BT responsive patients is required. We aimed to determine whether the defecation disorder type per high-resolution manometry (HRM) was predictive of BT response.
We analyzed clinical, manometric, and ultrasound endoscopic data from patients who underwent BT in our department between January 2015 and January 2016. Patients were classified into four groups per the following defecation disorder classification criteria: rectal pressure > 40 mmHg and anal paradoxical contraction (type I); rectal pressure < 40 mmHg and anal paradoxical contraction (type II); rectal pressure > 40 mmHg and incomplete anal relaxation (type III); and rectal pressure < 40 mmHg and incomplete anal relaxation (type IV). An experienced single operator conducted ten weekly 20-min sessions. Efficacy was evaluated with the visual analog scale.
Of 92 patients, 47 (50.5%) responded to BT. Type IV and type II defecation disorders were predictive of success (p = 0.03) (OR = 5.03 [1.02; 24.92]) and failure (p = 0.05) (OR = 0.41 [0.17; 0.99]), respectively. The KESS score severity before BT (p = 0.03) (OR = 0.9 [0.81; 0.99]) was also predictive of failure.
The manometry types identified according to the defecation disorder classification criteria were predictive of BT response. Our data confirm the role of three-dimensional HRM in the therapeutic management of anorectal functional disorders.
生物反馈疗法(BT)是一种简单有效的技术,可用于治疗出口性便秘和粪便失禁。已知有几个临床因素可预测 BT 反应,但仍有 50%的失败率。需要更好地选择对 BT 有反应的患者。我们旨在确定高分辨率测压(HRM)中的排便障碍类型是否可预测 BT 反应。
我们分析了 2015 年 1 月至 2016 年 1 月期间在我科接受 BT 的患者的临床、测压和超声内镜数据。根据以下排便障碍分类标准,患者被分为四组:直肠压力>40mmHg 和肛门矛盾收缩(I 型);直肠压力<40mmHg 和肛门矛盾收缩(II 型);直肠压力>40mmHg 和不完全肛门松弛(III 型);直肠压力<40mmHg 和不完全肛门松弛(IV 型)。一名经验丰富的操作员进行了十次每周 20 分钟的治疗。使用视觉模拟评分评估疗效。
在 92 名患者中,47 名(50.5%)对 BT 有反应。IV 型和 II 型排便障碍与成功(p=0.03)(OR=5.03[1.02;24.92])和失败(p=0.05)(OR=0.41[0.17;0.99])相关。BT 前 KESS 评分严重程度(p=0.03)(OR=0.9[0.81;0.99])也是失败的预测因素。
根据排便障碍分类标准确定的测压类型可预测 BT 反应。我们的数据证实了三维 HRM 在肛门直肠功能障碍治疗管理中的作用。